Journal: Science Advances
Article Title: ATR inhibition activates cancer cell cGAS/STING-interferon signaling and promotes antitumor immunity in small-cell lung cancer
doi: 10.1126/sciadv.ado4618
Figure Lengend Snippet: ( A ) Tumor growth curves (means ± SE) of vehicle, anti–PD-L1 antibody alone (300 μg per body, once weekly), ceralasertib alone (50 mg/kg, 5 of 7 days, once a day.), and ceralasertib plus anti–PD-L1 antibody groups in B6129F1 mice injected with RPP cells ( n = 4 in vehicle and anti–PD-L1 antibody group, n = 6 in the other groups). ( B to E ) RPP tumors were harvested on day 22 for immune profiling by flow cytometry ( n = 4 in vehicle and anti–PD-L1 antibody group, n = 6 in ceralasertib, n = 5 in ceralasertib plus anti–PD-L1 antibody group). Flow cytometry analysis of (B) CD45 + CD3 + T cells, (C) CD45 + CD3 + CD8 + T cells, (D) CD45 + CD3 + CD8 + ICOS + T cells, (E) effector memory CD8 + T cells: CD45 + CD3 + CD8 + CD44 hi CD62L lo . Percentages in (B), (C), and (E) were calculated relative to CD45 + cells, and percentages in (D) were calculated relative to CD45 + CD8 + cells. ( F ) CD8 immunohistochemistry was performed on tumor sections resected on day 22. Scale bar, 50 μm. ( G ) Tumor growth curves (means ± SE) of vehicle, anti–PD-L1 antibody alone, ceralasertib alone, and ceralasertib plus anti–PD-L1 antibody [same dose as (A)] groups in B6FVBF1/J mice injected with RPM cells ( n = 6 per group). ( H to K ) RPM tumors were harvested at day 18 for immune profiling by flow cytometry ( n = 5 in anti–PD-L1 group and n = 6 in the other groups). Flow cytometry analysis of (H) CD45 + CD3 + T cells, (I) CD45 + CD3 + CD8 + T cells, (J) CD45 + CD3 + CD8 + ICOS + T cells, and (K) effector memory CD8 + T cells: CD45 + CD3 + CD8 + CD44 hi CD62L lo . Percentages were the ratio to CD45 + cells. ( L ) CD8 immunohistochemistry of tumors resected on day 18. Scale bar, 50 μm. Cerala, ceralasertib. P values were calculated by one-way analysis of variance (ANOVA). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, and by Student’s t test for comparing ceralasertib alone and ceralasertib plus anti–PD-L1 antibody (A). ab, antibody. ns, not significant.
Article Snippet: Paraffin blocks were sectioned at 5-μm thickness, and immunohistochemistry was performed with anti-CD8a antibody [Cedarlane, HS-3610003(Sy)].
Techniques: Injection, Flow Cytometry, Immunohistochemistry